Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar ...

Partnerships between telehealth companies and pharmaceutical giants Pfizer and Eli Lilly raise concerns about conflicts of interest and inappropriate prescribing, according to a Senate investigation ...

Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly clarified that it would not partner with telehealth firms offering compounded ...

A High Rate of Prescriptions Are Written. The Report examined the number of prescriptions that resulted from patient participation in a Program, concluding that the rate was “high”. In one case, the ...

The opportunity to “ talk to a doctor now ” increases access to care, the drug companies say. But the legislators, and some ...

In April 2025, Eli Lilly and Company (Lilly) filed lawsuits in the U.S. District Court for the Northern District of California against telehealth companies, alleging the companies sell illegal ...

Eli Lilly will partner only with telehealth firms that agree to stop selling compound versions of its drug Zepbound or Novo Nordisk’s Wegovy, a move that sidelines Hims & Hers Health, Bloomberg ...

Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound An Eli Lilly & Co. Zepbound injection pens. Photographer: Shelby Knowles/Bloomberg By Madison Muller June 10, 2025 at 9:57 AM PDT ...

Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...

On Monday, Eli Lilly said that in July it will add the highest doses of Zepbound — 12.5 milligrams and 15 milligrams — to its website for patients paying cash.

In the last two years, both Pfizer and Eli Lilly launched websites that, among other things, connect patients with a telehealth provider for conditions their medications treat.